Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Price

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
Archives of General Psychiatry|January 1, 1989
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observationsL H Price, G A Ricaurte, J H Krystal, et al.
Journal of Affective Disorders|March 1, 1990
After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depressionA A Nierenberg, L H Price, D S Charney, et al.
Journal of Clinical Psychopharmacology|February 1, 1989
Use of yohimbine to counteract nortriptyline-induced orthostatic hypotensionJ P Seibyl, J H Krystal, L H Price, et al.
Psychoneuroendocrinology|March 31, 1999
Possible role of neuropeptides in obsessive compulsive disorderC J McDougle, L C Barr, W K Goodman, et al.
The Psychiatric Clinics of North America|December 1, 1993
The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesisC J McDougle, W K Goodman, J F Leckman, et al.
Psychopharmacology|January 1, 1992
A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant actionG J Marek, C J McDougle, L H Price, et al.
Psychiatry Research|May 1, 1985
Noradrenergic function and the cortisol response to dexamethasone in depressionA L Rubin, L H Price, D S Charney, et al.
Drug Safety|August 1, 1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorderL L Carpenter, C J McDougle, C N Epperson, et al.
Psychiatric Services (Washington, D.C.)|April 3, 1998
Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depressionL Calvocoressi, D Libman, S J Vegso, et al.
Journal of Affective Disorders|March 14, 2001
Adjunctive gabapentin in treatment-resistant depression: a retrospective chart reviewS Yasmin, L L Carpenter, Z Leon, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
Archives of General Psychiatry|January 1, 1989
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-methylenedioxymethamphetamine (MDMA) users. Preliminary observationsL H Price, G A Ricaurte, J H Krystal, et al.
Journal of Affective Disorders|March 1, 1990
After lithium augmentation: a retrospective follow-up of patients with antidepressant-refractory depressionA A Nierenberg, L H Price, D S Charney, et al.
Journal of Clinical Psychopharmacology|February 1, 1989
Use of yohimbine to counteract nortriptyline-induced orthostatic hypotensionJ P Seibyl, J H Krystal, L H Price, et al.
Psychoneuroendocrinology|March 31, 1999
Possible role of neuropeptides in obsessive compulsive disorderC J McDougle, L C Barr, W K Goodman, et al.
The Psychiatric Clinics of North America|December 1, 1993
The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesisC J McDougle, W K Goodman, J F Leckman, et al.
Psychopharmacology|January 1, 1992
A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant actionG J Marek, C J McDougle, L H Price, et al.
Psychiatry Research|May 1, 1985
Noradrenergic function and the cortisol response to dexamethasone in depressionA L Rubin, L H Price, D S Charney, et al.
Drug Safety|August 1, 1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorderL L Carpenter, C J McDougle, C N Epperson, et al.
Psychiatric Services (Washington, D.C.)|April 3, 1998
Global functioning of inpatients with obsessive-compulsive disorder, schizophrenia, and major depressionL Calvocoressi, D Libman, S J Vegso, et al.
Journal of Affective Disorders|March 14, 2001
Adjunctive gabapentin in treatment-resistant depression: a retrospective chart reviewS Yasmin, L L Carpenter, Z Leon, et al.
Pageof 20